Consensus Cingulate Inc.

Equities

CING

US17248W2044

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
0.888 ^USD	+0.15%		-14.62%	-88.39%

May. 07	Certain Pre-Funded Warrants of Cingulate Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	CI
May. 07	Certain Warrants of Cingulate Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	CI

Evolution of the average Target Price on Cingulate Inc.

Price target over the last 5 years

History of analyst recommendation changes

eab3d03e93128255c2dec.9AOsvRatRtKQOnghuWJUVi-5Gfd_vfmy2qYQoWoSd1w.lVWf6nzkNYPADB9A7zo3D2vzfYIliJSCmcRplzJ3BA3EeuOIRpULlNxNGw~41f433913303c02801c6a9d007d7523f

Analyst Recommendations on Cingulate Inc.

HC Wainwright Adjusts Price Target on Cingulate to $8 From $3.50, Maintains Buy Rating	Jan. 05	MT
Laidlaw Downgrades Cingulate to Hold From Buy	Dec. 22	MT
Maxim Group Downgrades Cingulate to Hold From Buy	Dec. 18	MT
HC Wainwright Adjusts Price Target on Cingulate to $3.50 From $5.50, Maintains Buy Rating	23-09-26	MT
HC Wainwright Starts Cingulate at Buy With $5.50 Price Target	23-01-17	MT
Maxim Starts Cingulate at Buy With $3 Price Target	22-11-22	MT
Laidlaw Starts Cingulate at Buy With $8.50 Price Target	22-01-20	MT
Aegis Capital Initiates Coverage on Cingulate With Buy Rating, $9 Price Target	22-01-11	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.888 USD

Average target price

15 USD

Spread / Average Target

+1,589.19%

High Price Target

22 USD

Spread / Highest target

+2,377.48%

Low Price Target

8 USD

Spread / Lowest Target

+800.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cingulate Inc.

HC Wainwright
Laidlaw & Co.
Maxim
Aegis Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar